Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Vitamin D Deficiency 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Polycystic Ovary Syndrome 2Neoplasms 1Multiple Sclerosis, Relapsing-Remitting 1Giant Cell Tumor of Bone 1Gastrointestinal Neoplasms 1Cognitive Dysfunction 1Cholangiocarcinoma 1Carcinoma, Ovarian Epithelial 1Carcinoma, Hepatocellular 1Cachexia 1

Interventions

Denosumab 2Vitamin D 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Giant Cell Tumor of Bone × Vitamin D × Clear all
NCT04255576 2022-10-14

Efficacy and Safety of JMT103 in Patients With Giant Cell Tumor of Bone

Shanghai JMT-Bio Inc.

Phase 1/2 Unknown
139 enrolled

Giant Cell Tumor of Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡